Complete Filing Data
NU RIDE INC. reported Stockholders Equity of $2.60 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean NU RIDE INC. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Net Income * | -$619.0K | -$8.1M | -$343.1M | -$282.4M | -$410.4M | -$124.1M | $3.0M |
| Operating Income Loss | -$3.8M | -$10.9M | -$348.9M | -$387.3M | -$400.5M | -$102.3M | -$618.6K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$619.0K | -$8.1M | -$343.1M | -$282.4M | -$410.4M | -$124.1M | $3.9M |
| Operating Expenses | $3.8M | $10.9M | $259.7M | $357.5M | $400.5M | $102.3M | |
| Other Nonoperating Income Expense | $16.0K | -$251.0K | $123.0K | $788.0K | -$10.1M | -$20.9M | |
| Research And Development Expense | $33.3M | $107.8M | $284.0M | $71.0M | |||
| Selling And Marketing Expense | $138.3M | $105.4M | $31.3M | ||||
| Income Tax Expense Benefit | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Interest Income Expense Nonoperating Net | $3.2M | $200.0K | -$901.0K | ||||
| Net Income Loss To Common Shareholders | -$345.6M | -$282.7M | -$410.4M | -$124.1M | |||
| General And Administrative Expense | $618.6K | ||||||
| Investment And Interest Income Expense Nonoperating Net | $6.6M | $3.2M | |||||
| Impairment Of Long Lived Assets Held For Use | $140.7M | $111.4M | |||||
| Revenue From Contract With Customer Including Assessed Tax | $2.3M | $194.0K | |||||
| Cost Of Goods And Services Sold | $91.6M | $30.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | $955.0K | $742.0K | -$1.2M | $338.0K | $1.5M | -$8.5M | -$16.5M | -$154.5M | -$171.7M | -$154.4M | $63.7M | -$89.6M | -$95.8M | -$108.2M | -$125.2M | -$42.5M | -$8.0M | -$11.9M | $976.2K | $1.1M | $262.9K | -$1.7K |
| Operating Income Loss | $417.0K | -$357.0K | -$1.8M | -$519.0K | $533.0K | -$9.5M | -$17.5M | -$153.6M | -$174.2M | -$154.8M | -$40.5M | -$87.9M | -$99.3M | -$110.3M | -$106.2M | -$42.0M | -$9.9M | -$12.0M | -$149.8K | -$153.8K | -$88.3K | -$1.7K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $955.0K | $742.0K | -$1.2M | $338.0K | $1.5M | -$8.5M | -$16.5M | -$154.5M | -$171.7M | -$154.4M | $63.7M | -$89.6M | -$95.8M | -$108.2M | -$125.2M | -$42.5M | -$8.0M | -$11.9M | $1.3M | $1.4M | $343.0K | -$1.7K |
| Operating Expenses | -$417.0K | $357.0K | $1.8M | $519.0K | -$533.0K | $9.5M | $17.5M | $95.0M | $143.6M | $154.8M | $40.5M | $87.9M | $99.3M | $110.3M | $106.2M | $42.0M | $9.9M | $12.0M | ||||
| Other Nonoperating Income Expense | -$22.0K | -$37.0K | -$55.0K | -$65.0K | -$98.0K | -$240.0K | $93.0K | $64.0K | -$643.0K | $2.0M | -$1.5M | $3.5M | $1.9M | -$19.1M | $58.0K | $2.3M | $126.0K | |||||
| Research And Development Expense | $5.7M | $12.3M | $14.4M | $19.8M | $10.5M | $61.9M | $56.9M | $76.5M | $91.8M | $30.0M | $4.8M | $8.5M | ||||||||||
| Selling And Marketing Expense | $57.7M | $14.7M | $60.1M | $29.9M | $26.0M | $31.3M | $33.8M | $14.4M | $12.0M | $5.2M | $3.5M | |||||||||||
| Income Tax Expense Benefit | $13.7K | $182.3K | $286.0K | $320.7K | $80.1K | |||||||||||||||||
| Interest Income Expense Nonoperating Net | $2.4M | $1.1M | $383.0K | -$258.0K | $9.0K | $260.0K | $127.0K | -$557.0K | -$363.0K | -$1.0K | ||||||||||||
| Net Income Loss To Common Shareholders | -$344.0K | $810.0K | -$9.1M | -$15.9M | -$153.9M | -$171.1M | -$154.4M | $63.7M | -$89.6M | |||||||||||||
| General And Administrative Expense | $484.6K | $162.3K | $149.8K | $153.8K | $88.3K | $1.7K | ||||||||||||||||
| Investment And Interest Income Expense Nonoperating Net | $912.0K | $1.0M | $1.1M | $1.4M | $1.6M | $2.4M | $1.1M | $383.0K | ||||||||||||||
| Impairment Of Long Lived Assets Held For Use | $738.0K | $25.0M | $114.4M | $74.9M | ||||||||||||||||||
| Revenue From Contract With Customer Including Assessed Tax | $2.2M | $189.0K | ||||||||||||||||||||
| Cost Of Goods And Services Sold | $60.7M | $30.8M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $2.6M | $6.8M | $13.5M | $351.8M | $539.6M | $630.7M | $8.6M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $244.0M | $629.8M | $2.2M | |||||
| Cash And Cash Equivalents At Carrying Value | $34.4M | $23.1M | $87.1M | $121.4M | $244.0M | $629.8M | $2.2M | |
| Retained Earnings Accumulated Deficit | -$1.18B | -$1.18B | -$1.17B | -$827.2M | -$544.8M | -$134.4M | -$10.4M | -$1.7K |
| Liabilities Current | $991.0K | $1.1M | $15.4M | $68.8M | $147.6M | $34.1M | $25.0M | $96.7K |
| Liabilities And Stockholders Equity | $47.0M | $53.2M | $92.2M | $452.3M | $688.8M | $767.2M | $33.5M | $120.0K |
| Liabilities | $6.0M | $10.9M | $45.9M | $70.3M | $149.2M | $136.5M | $25.0M | $96.7K |
| Assets Current | $44.8M | $53.2M | $92.1M | $255.9M | $291.1M | $654.4M | $2.2M | $20.0K |
| Assets | $47.0M | $53.2M | $92.2M | $452.3M | $688.8M | $767.2M | $33.5M | $120.0K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $11.3M | -$64.0M | -$34.3M | -$122.7M | -$385.7M | $627.6M | ||
| Accrued And Other Liabilities Current | $126.0K | $207.0K | $1.7M | $17.6M | $35.5M | $1.5M | $415.0K | |
| Accounts Payable Current | $464.0K | $136.0K | $933.0K | $12.8M | $12.1M | $32.5M | $1.8M | |
| Common Stock Value | $24.0K | $19.0K | $17.0K | $7.0K | ||||
| Derivative Liabilities Noncurrent | $1.4M | $1.6M | $101.4M | |||||
| Property Plant And Equipment Net | $193.8M | $382.7M | $101.7M | $20.3M | ||||
| Gain Loss On Sale Of Property Plant Equipment | -$916.0K | $100.9M | $2.3M | |||||
| Dividend Preferred Stock | $2.9M | $2.7M | $2.5M | $261.0K | ||||
| Prepaid Expense And Other Assets Current | $47.1M | $24.7M | ||||||
| Noncash Or Part Noncash Acquisition Fixed Assets Acquired Via Debt | $200.0M | $2.2M | $5.6M | |||||
| Intangible Assets Net Including Goodwill | $1.0M | $11.1M | $11.1M | |||||
| Temporary Equity Carrying Amount Attributable To Parent | $30.3M | |||||||
| Other Assets Noncurrent | $2.2M | $30.0K | $2.7M | $13.9M | ||||
| Liabilities Subject To Compromise | $5.0M | $9.9M | $30.5M | |||||
| Temporary Equity Accretion Of Dividends | $2.9M | $2.7M | $2.5M | |||||
| Other Non Cash Changes | -$2.2M | -$384.0K | $10.9M | $23.5M | ||||
| Other Assets Current | $176.0K | $139.0K | $2.2M | $1.0M | ||||
| Accrued Professional Fees Current And Noncurrent | $401.0K | $721.0K | $12.8M | $38.4M | ||||
| Stock Issued During Period Value Common Stock Subject To Possible Redemption | -$269.7M | |||||||
| Interest Earned On Marketable Securities Held In Trust Account | $4.5M | |||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $34.4M | $23.1M | $87.1M | $121.4M | ||||
| Additional Paid In Capital Common Stock | $24.3K | |||||||
| Accounts Payable And Accrued Liabilities Current | $1.7K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $4.8M | $4.4M | $4.9M | $8.2M | $8.5M | $7.7M | $13.7M | $29.0M | $181.8M | $412.4M | $535.8M | $454.5M | $532.5M | $599.0M | $703.3M | -$45.3M | -$3.5M | $3.2M | $5.0M | $5.0M | $5.0M | $23.4K | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $57.0M | $62.3M | $77.4M | $87.1M | $93.7M | $115.7M | $108.1M | $121.4M | $154.2M | $235.7M | $203.6M | $233.8M | $365.9M | $587.0M | $19.7M | $585.0K | $429.0K | ||||||||||
| Cash And Cash Equivalents At Carrying Value | $18.2M | $26.8M | $28.0M | $26.1M | $20.9M | $19.7M | $93.7M | $115.7M | $108.1M | $154.2M | $235.7M | $203.6M | $233.8M | $365.9M | $587.0M | $857.1K | $988.8K | $1.2M | $1.2M | $1.3M | $20.0K | ||||||
| Retained Earnings Accumulated Deficit | -$1.18B | -$1.18B | -$1.18B | -$1.18B | -$1.18B | -$1.18B | -$1.17B | -$1.15B | -$998.9M | -$725.2M | -$570.8M | -$634.4M | -$463.7M | -$367.9M | -$259.7M | $3.2M | $3.6M | $2.3M | $1.4M | $261.2K | |||||||
| Liabilities Current | $977.0K | $837.0K | $860.0K | $1.8M | $1.7M | $11.1M | $22.6M | $16.9M | $58.8M | $86.1M | $60.8M | $203.1M | $87.9M | $81.4M | $67.0M | $573.3K | $321.6K | $234.3K | $155.9K | $177.7K | |||||||
| Liabilities And Stockholders Equity | $48.6M | $49.7M | $51.5M | $58.3M | $63.7M | $79.1M | $108.0M | $163.1M | $272.4M | $501.1M | $598.2M | $660.8M | $623.9M | $687.3M | $779.1M | $285.3M | $285.4M | $284.1M | $283.0M | $281.9M | |||||||
| Liabilities | $6.2M | $8.4M | $10.4M | $15.2M | $21.1M | $38.0M | $62.2M | $102.6M | $59.7M | $88.6M | $62.4M | $206.2M | $91.4M | $88.3M | $75.8M | $10.4M | $10.1M | $10.0M | $10.0M | $10.0M | |||||||
| Assets Current | $48.6M | $49.7M | $51.5M | $58.3M | $63.7M | $79.1M | $100.8M | $154.4M | $192.0M | $252.2M | $282.8M | $237.9M | $256.7M | $385.1M | $613.0M | $940.8K | $1.1M | $1.4M | $1.4M | $1.5M | |||||||
| Assets | $48.6M | $49.7M | $51.5M | $58.3M | $63.7M | $79.1M | $108.0M | $163.1M | $272.4M | $501.1M | $598.2M | $660.8M | $623.9M | $687.3M | $779.1M | $285.3M | $285.4M | $284.1M | $283.0M | $281.9M | |||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $8.2M | -$9.7M | -$13.3M | -$40.5M | -$42.7M | -$1.7M | |||||||||||||||||||||
| Accrued And Other Liabilities Current | $117.0K | $172.0K | $195.0K | $406.0K | $281.0K | $355.0K | $2.8M | $13.4M | $50.4M | $57.0M | $34.4M | $39.3M | $39.2M | $32.6M | $8.0M | ||||||||||||
| Accounts Payable Current | $415.0K | $111.0K | $153.0K | $437.0K | $333.0K | $2.5M | $1.4M | $3.5M | $8.4M | $15.6M | $13.0M | $13.8M | $48.7M | $48.8M | $59.0M | ||||||||||||
| Common Stock Value | $24.0K | $24.0K | $24.0K | $24.0K | $24.0K | $24.0K | $24.0K | $22.0K | $21.0K | $20.0K | $18.0K | $18.0K | $18.0K | ||||||||||||||
| Derivative Liabilities Noncurrent | $603.0K | $779.0K | $889.0K | $2.5M | $1.6M | $3.2M | $100.9M | $3.5M | $6.9M | $7.8M | $100.9M | ||||||||||||||||
| Property Plant And Equipment Net | $78.1M | $220.0M | $286.9M | $407.8M | $362.4M | $286.3M | $154.9M | ||||||||||||||||||||
| Gain Loss On Sale Of Property Plant Equipment | -$175.0K | -$2.6M | $101.7M | $2.3M | $2.3M | ||||||||||||||||||||||
| Dividend Preferred Stock | $738.0K | $723.0K | $709.0K | $682.0K | $668.0K | $655.0K | -$630.0K | -$618.0K | -$605.0K | ||||||||||||||||||
| Prepaid Expense And Other Assets Current | $16.7M | $9.0M | $20.5M | $37.5M | $43.1M | $34.4M | $22.9M | $19.2M | $26.0M | ||||||||||||||||||
| Noncash Or Part Noncash Acquisition Fixed Assets Acquired Via Debt | $256.0K | $5.3M | $4.6M | ||||||||||||||||||||||||
| Intangible Assets Net Including Goodwill | $1.0M | $1.0M | $1.0M | $11.1M | $11.1M | ||||||||||||||||||||||
| Temporary Equity Carrying Amount Attributable To Parent | $34.8M | $34.1M | $33.4M | $32.8M | $32.1M | $31.5M | $32.8M | $269.9M | $270.3M | $269.7M | $269.0M | $268.1M | $267.0M | ||||||||||||||
| Other Assets Noncurrent | $728.0K | $1.8M | $2.2M | $27.9M | $27.5M | $14.0M | $4.8M | $4.8M | |||||||||||||||||||
| Liabilities Subject To Compromise | $5.2M | $7.5M | $9.6M | $13.5M | $19.4M | $26.9M | $39.0M | $85.0M | |||||||||||||||||||
| Temporary Equity Accretion Of Dividends | $738.0K | $723.0K | $709.0K | $682.0K | $668.0K | $655.0K | $600.0K | $600.0K | $600.0K | ||||||||||||||||||
| Other Non Cash Changes | -$1.1M | $4.4M | $19.1M | ||||||||||||||||||||||||
| Other Assets Current | $352.0K | $330.0K | $229.0K | $930.0K | $1.1M | $1.3M | $774.0K | ||||||||||||||||||||
| Accrued Professional Fees Current And Noncurrent | $445.0K | $554.0K | $512.0K | $934.0K | $1.1M | $8.3M | $13.3M | ||||||||||||||||||||
| Stock Issued During Period Value Common Stock Subject To Possible Redemption | $383.2K | -$573.6K | -$976.2K | -$1.1M | -$267.0M | ||||||||||||||||||||||
| Interest Earned On Marketable Securities Held In Trust Account | $115.0K | $918.2K | $1.4M | $1.6M | $431.2K | ||||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $18.2M | $29.5M | $31.3M | $57.0M | $62.3M | $77.4M | |||||||||||||||||||||
| Additional Paid In Capital Common Stock | $1.8M | $1.4M | $2.0M | $2.7M | $3.6M | $4.7M | |||||||||||||||||||||
| Accounts Payable And Accrued Liabilities Current | $430.2K | $192.3K | $289.8K | $234.3K | $119.1K | $79.1K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$7.2M | -$35.1M | -$137.2M | -$213.8M | -$388.0M | -$99.6M | -$1.4M |
| Net Cash Provided By Used In Investing Activities | $18.6M | -$28.8M | $102.9M | -$114.9M | -$285.5M | -$50.2M | -$279.0M |
| Share Based Compensation | $432.0K | $3.5M | $7.4M | $18.8M | $18.7M | $2.8M | |
| Net Cash Provided By Used In Financing Activities | -$106.0K | $206.0M | $287.8M | $777.4M | $281.5M | ||
| Increase Decrease In Accounts Payable | $328.0K | -$797.0K | -$11.9M | $2.5M | -$17.0M | $25.8M | |
| Proceeds From Issuance Of Common Stock | $2.1M | $6.4M | $6.4M | $2.8K | |||
| Increase Decrease In Accrued Liabilities And Due To Related Party | -$22.0M | -$12.9M | $19.7M | $32.8M | -$531.0K | ||
| Increase Decrease In Prepaid Expense | -$15.7M | -$10.6M | $34.1M | $24.7M | $97.1K | ||
| Payments To Acquire Property Plant And Equipment | $10.2M | $54.6M | $284.5M | $52.6M | |||
| Proceeds From Warrant Exercises | $82.0M | $30.7M | |||||
| Increase Decrease In Accounts Receivable | -$204.0K | $203.0K | -$21.0K | $21.0K | |||
| Proceeds From Sale Of Property Plant And Equipment | $11.0M | $40.0M | $2.4M | ||||
| Payments To Acquire Short Term Investments | $29.2M | $38.8M | $32.1M | $100.3M | $1.0M | ||
| Proceeds From Convertible Debt | $38.8M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 | Q3 2020 | Q1 2020 | Q1 2019 | Q4 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$1.8M | -$9.6M | -$38.1M | -$69.0M | -$71.5M | -$7.9M | -$170.4K | ||
| Net Cash Provided By Used In Investing Activities | $10.0M | $24.8M | -$21.9M | -$54.3M | $200.1K | -$280.0M | |||
| Share Based Compensation | $108.0K | $3.4M | $2.4M | $3.9M | $1.9M | $130.0K | |||
| Net Cash Provided By Used In Financing Activities | -$106.0K | $50.5M | $83.1M | $6.1M | $281.5M | $20.0K | |||
| Increase Decrease In Accounts Payable | $17.0K | $1.5M | -$4.1M | -$1.5M | $27.4M | $3.9M | |||
| Proceeds From Issuance Of Common Stock | $477.0K | $1.1M | $6.1M | $2.8K | $25.0K | ||||
| Increase Decrease In Accrued Liabilities And Due To Related Party | -$318.0K | -$4.6M | -$5.7M | $3.8M | $6.5M | -$9.0K | |||
| Increase Decrease In Prepaid Expense | -$12.8M | -$10.0M | $1.3M | $55.0K | $159.6K | ||||
| Payments To Acquire Property Plant And Equipment | $7.9M | $21.9M | $54.3M | ||||||
| Proceeds From Warrant Exercises | $82.0M | ||||||||
| Increase Decrease In Accounts Receivable | -$16.0K | ||||||||
| Proceeds From Sale Of Property Plant And Equipment | |||||||||
| Payments To Acquire Short Term Investments | $22.2M | ||||||||
| Proceeds From Convertible Debt | $37.8M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.22 | -$0.67 | -$21.67 | -$20.32 | -$2.27 | -$1.28 | ||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Weighted Average Number Of Shares Outstanding Basic | 16.1M | 16.1M | 15.9K | 13.9M | 180.7M | 96.7M | ||
| Weighted Average Number Of Diluted Shares Outstanding | 16.1M | 16.1M | 15.9K | 13.9M | 180.7M | 96.7M | ||
| Earnings Per Share Basic | $-0.22 | $-0.67 | $-21.67 | $-20.32 | $-2.27 | $-1.28 | ||
| Common Stock Shares Authorized | 450.0M | 450.0M | 450.0M | 300.0M | 300.0M | |||
| Common Stock Shares Outstanding | 15.9M | 196.4M | 168.0M | 68.3M | ||||
| Common Stock Shares Issued | 15.9M | 196.4M | 168.0M | 68.3M | ||||
| Temporary Equity Shares Authorized | 12.0M | 12.0M | 12.0M | |||||
| Temporary Equity Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | |||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 96.7M | |||||||
| Preferred Stock Shares Authorized | 1.0M | |||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | $0.01 | -$0.12 | -$0.02 | $0.05 | -$0.57 | -$1.03 | -$9.69 | -$10.71 | -$10.93 | $4.75 | -$0.46 | -$0.54 | -$0.61 | -$0.72 | -$0.57 | -$0.11 | -$0.16 | ||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||
| Weighted Average Number Of Shares Outstanding Basic | 16.1K | 16.1K | 16.1K | 16.1K | 16.1K | 16.0K | 16.0M | 15.9M | 16.0M | 14.1M | 13.4M | 196.5M | 178.8M | 176.6M | 174.3M | ||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 16.1K | 17.5K | 16.1K | 16.1K | 17.5K | 16.0K | 16.0M | 15.9M | 16.0M | 14.1M | 13.4M | 196.5M | 178.8M | 176.6M | 174.3M | ||||||||
| Earnings Per Share Basic | $0.01 | $-0.12 | $-0.02 | $0.05 | $-0.57 | $-1.03 | $-9.69 | $-10.71 | $-10.93 | $4.75 | $-0.46 | $-0.54 | $-0.61 | $-0.72 | |||||||||
| Common Stock Shares Authorized | 450.0M | 450.0M | 450.0M | 450.0M | 450.0M | 450.0M | 450.0M | 450.0M | 450.0M | 450.0M | 450.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | |||||||
| Common Stock Shares Outstanding | 16.1M | 16.1M | 16.1M | 16.0M | 16.0M | 16.0M | 239.0M | 216.9M | 205.9M | 196.4M | 182.1M | 176.6M | 176.6M | ||||||||||
| Common Stock Shares Issued | 16.1M | 16.1M | 16.1M | 16.0M | 16.0M | 16.0M | 239.0M | 216.9M | 205.9M | 197.0M | 182.1M | 176.6M | 176.6M | ||||||||||
| Temporary Equity Shares Authorized | 12.0M | 12.0M | 12.0M | 12.0M | 12.0M | 12.0M | 12.0M | 12.0M | 12.0M | 12.0M | 12.0M | ||||||||||||
| Temporary Equity Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 178.8M | 176.6M | 174.3M | 74.0M | 74.0M | 71.9M | |||||||||||||||||
| Preferred Stock Shares Authorized | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | |||||||||||||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $432.0K | $3.5M | $7.4M | $18.8M | $18.7M | $2.8M | |
| Stock Issued During Period Value New Issues | $2.1M | $6.4M | $6.4M | $2.8K | |||
| Additional Paid In Capital | $1.18B | $1.18B | $1.18B | $1.18B | $1.08B | $765.2M | $18.9M |
| Stock Issued During Period Value Warrants Exercised | $194.8M | $53.7M | |||||
| Stock Issued During Period Value Restricted Stock Award Gross | $106.0K | $65.0K | -$684.0K | ||||
| Legal And Litigation Accruals | -$3.0M | -$6.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $107.0K | $108.0K | $108.0K | $45.0K | $23.0K | $3.4M | $2.3M | $2.4M | $4.4M | $2.6M | $3.9M | $6.6M | $3.8M | $1.9M | $708.0K | $1.2M | $130.0K | ||
| Stock Issued During Period Value New Issues | $1.2M | $616.0K | $2.7M | $48.0K | $1.1M | $6.4M | $2.8K | ||||||||||||
| Additional Paid In Capital | $1.18B | $1.18B | $1.18B | $1.19B | $1.19B | $1.19B | $1.18B | $1.18B | $1.18B | $1.14B | $1.11B | $1.09B | $996.1M | $966.8M | $962.9M | ||||
| Stock Issued During Period Value Warrants Exercised | $194.8M | ||||||||||||||||||
| Stock Issued During Period Value Restricted Stock Award Gross | $106.0K | -$20.0K | -$46.0K | ||||||||||||||||
| Legal And Litigation Accruals | -$1.6M | -$1.3M | -$172.0K | -$1.8M | -$2.0M | -$544.0K |
Most recent annual filing with the SEC: March 26, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.